SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines

Molecular Biology Reports

Volumn 40, Issue 7, 2013, Pages 4139-4146

  Pan, Feng ^a   Ma, Shijie ^a   Cao, Weike ^a   Liu, Haining ^a   Chen, Fengli ^a   Chen, Xiaofei ^a   Shi, Ruihua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chemokines; Expression; Invasiveness; p38 MAPK; Pancreatic cancer

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; ARTICLE; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; METASTASIS; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PHOSPHORYLATION; RECEPTORS, CXCR4;

EID: 84879421338     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2225-4     Document Type: Article

References (34)

1. Iovanna J, Gonçalves A, Turrini O et al (2012) Current knowledge on pancreatic cancer. Front Oncol. doi: 10.3389/fonc.2012.00006
2. Vaccaro V, Bria E, Iapicca P et al (2012) Molecular and genetic bases of pancreatic cancer. Curr Drug Targets 13(6):731-743
3. Balkwill F (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14(3):171-179
4. Domanska UM, Nagengast WB, Timmer-Bosscha H et al (2012) A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer. doi: 10.1016/j.ejca.2012.05.005
5. Cacina C, Iyibozkurt AC, Yaylim-Eraltan I et al (2012) Genetic variants of SDF-1 and CXCR4 genes in endometrial carcinoma. Mol Biol Rep 39(2):1225-1229
6. Orimo A, Sgroi DC, Arenzana-Seisdedos F et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121(3):335-348
7. Pietkiewicz PP, Lianeri M, Jagodzinski PP et al (2010) Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells. Biomed Pharmacother 64(1):54-57
8. Olumi AF, Hayward SW, Carroll PR et al (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59(19):5002-5011
9. Burger JA, Peled A (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23(1):43-52
10. Zhao FL, Guo W (2011) Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma. Mol Biol Rep 38(2):1039-1045
11. Vargová V, Pytliak M, Mechírová V (2012) Matrix metalloproteinases. EXS 103:1-33
12. Liang JJ, Bruggeman R, Zaino RJ (2010) High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomark Prev 19(10):2598-2604
13. Marchesi F, Leone BE, Zerbi A (2004) Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64(22):8420-8427
14. Koshiba T, Miyamoto Y, Ida J (2000) Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6(9):3530-3535
15. Zhang R, Weber GF, Zhang G et al (2011) Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One 6(e23831):e23838
16. Zhou Y, Hao C, Yong VW (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277(51):49481-49487
17. Schrader AJ, Templin M et al (2002) CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86(8):1250-1256
18. Sun YX, Shelburne CE, Lopatin DE et al (2003) Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89(3):462-473
19. Robledo MM, Longo N, Rodríguez-Frade JM et al (2001) Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 276(48):45098-45105
20. Kijima T, Ma PC, Tibaldi EV et al (2002) Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62(21):6304-6311
21. Darash-Yahana M, Abramovitch R, Zeira E et al (2004) Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 18(11):1240-1242
22. Kang Y, Shu W, Drobnjak M et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3(6):537-549
23. Helbig G, Bhat-Nakshatri P, Kumar S et al (2003) NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278(24):21631-21638
24. Theodoropoulos GE, Michalopoulos NV, Zambirinis CP et al (2010) Analysis of the stromal cell-derived factor 1-3′A gene polymorphism in pancreatic cancer. Mol Med Rep 3(4):693-698
25. Scotton CJ, Scott K, Stamp G et al (2002) Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62(20):5930-5938
26. Bachelder RE, Mercurio AM (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62(24):7203-7206
27. Nagase H, Yamaguchi M, Fujisawa T et al (2000) Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation. J Immunol 164(11):5935-5943
28. Yu T, Helman JI, Wen Y et al (2011) CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway. Mol Cancer Res 9(2):161-172
29. Bhoopathi P, Gogineni VR, Gujrati M et al (2011) MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors. Gene Ther 18(7):692-701
30. Ganju RK, Meyer J, Dutt P et al (1998) The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273(36):23169-23175
31. Delgado-Martín C, Pablos JL, Riol-Blanco L, Rodríguez- Fernández JL (2011) Chemokine CXCL12 uses CXCR4 and a signaling core formed by bifunctional Akt, extracellular signal-regulated kinase (ERK)1/2, and mammalian target of rapamycin complex 1 (mTORC1) proteins to control chemotaxis and survival simultaneously in mature dendritic cells. J Biol Chem 286(43):37222-37236
32. Wang Z, Ma Q (2007) Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer. Med Hypotheses 69(4):816-820
33. Chua AW, Rajendran P, Shanmugam MK et al (2010) Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-kB activation in breast and pancreatic tumor cells. Biochem Pharmacol 80(10):1553-1562
34. Guleng B, Ohta M, Kanai F et al (2005) Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65(13):5864-5871